1. Aboyans V, Ricco J, Bartelink M, Björck M, Brodmann M, Cohnert T, Collet J, Czerny M, De Carlo M, Debus S, Espinola-Klein C, Kahan T, Kownator S, Mazzolai L, Ross Naylor A, Roffi M, Röther J, Sprynger M, Tendera M, Tepe G, Venermo M, Vlachopoulos C, Desormais I. 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS): document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries “The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS)”. Eur Heart J. 2018;39(9):793–816.
2. Abualhin M, Sonetto A, Faggioli G, Mirelli M, Freyrie A, Gallitto E, Spath P, Stella A, Gargiulo M. Outcomes of duplex-guided paramalleolar and inframalleolar bypass in patients with critical limb ischemia. Ann Vasc Surg. 2018;53:154–64.
3. Allie D, Hebert C, Lirtzman M, Wyatt C, Keller V, Khan M, Khan M, Fail P, Vivekananthan K, Mitran E, Allie S, Chaisson G, Stagg S, Allie A, McElderry M, Walker C. Critical limb ischemia: a global epidemic. A critical analysis of current treatment unmasks the clinical and economic costs of CLI. EuroIntervention. 2005;1(1):75–84.
4. Allie D, Hebert C, Ingraldi A, Patlola R, Walker C. 24-carat gold, 14-carat gold, or platinum standards in the treatment of critical limb ischemia: bypass surgery or endovascular intervention? J Endovasc Ther. 2009;16(1):134–46.
5. Alonso A, Garcia L. The costs of critical limb ischemia. Endovascular Today. 2011:32–6.